Literature DB >> 19093512

Seroepidemiologic study of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and syphilis infections in Iranian blood donors.

Hossein Khedmat1, Farahnaz Fallahian, Hassan Abolghasemi, Seyed-Moayed Alavian, Bashir Hajibeigi, Seyyed Mohammad Miri, Amir Masoud Jafari.   

Abstract

To determine the frequency of hepatitis B, hepatitis C, Human Immunodeficiency Virus (HIV) and syphilis infections in Iranian blood donors. The prevalence of serological markers of hepatitis B, hepatitis C, HIV and syphilis infections were evaluated in 318029 consecutive volunteer blood donors attending to Tehran blood transfusion service from March 2005 to March 2006. Those positive for hepatitis B surface antigen, anti-HCV, anti-HIV1/2 and VDRL (venereal disease research laboratory) reactivity were analyzed with a second independent HBsAg enzyme immunoassay (EIA) and neutralization assay; an additional independent anti-HCV EIA and HCV-RIBA assay; second independent anti-HIV1/2 test, HIV western blot and fluorescent Treponemal Antibody Absorbed (FTA-ABS), respectively. In 318029 participants, prevalence of positive HBsAg, HCV RNA, HIV western blot and FTA-ABS was 1684 (0.487%), 323 (0.093%), 11 (0.003%) and 19 (0.005%), respectively. In 1014 subjects randomly selected from these 318029 participants, besides standard interview, physical exam and routine serologic tests; anthropometric and biochemical were studies. In this selected group frequency of HBsAg was 3 (0.29, 95% CI: 0-0.64%); frequency of anti-HCV was 21 (2.07%), but it was (0.09%, 95% CI: 0-0.30%) by confirmatory HCV RNA test; frequency of HIV-Abl, 2 was 8 (0.78%), but it was 2 (0.19%, 95% CI: 0-0.48%) by confirmatory test; frequency of RPR was 0 (0%, 95% CI: 0-0.30%). Despite excluding subjects with high-risk behaviors by standard interview and physical examination, still a few asymptomatic hepatitis B, hepatitis C, HIV-infected subjects existed among volunteer blood donors with demographic and biochemical findings similar to non-infected ones.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19093512     DOI: 10.3923/pjbs.2007.4461.4466

Source DB:  PubMed          Journal:  Pak J Biol Sci        ISSN: 1028-8880


  11 in total

1.  Frequency of HIV and HCV Co-Infections in Chronic HBV Patients Referred to Taleghani Hospital, Tehran, Iran from 2006 to 2010.

Authors:  Seyed Mohammad Ebrahim Tahaei; Seyed Reza Mohebbi; Pedram Azimzadeh; Mohsen Vahedi; Shohreh Almasi; Sara Romani; Afsaneh Sharifian; Faramarz Derakhshan; Mohammad Reza Zali
Journal:  Hepat Mon       Date:  2011-12-20       Impact factor: 0.660

Review 2.  Epidemiology of hepatitis C virus in Iran.

Authors:  Reza Taherkhani; Fatemeh Farshadpour
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

Review 3.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 4.  Hepatitis C virus infection in the Middle East and North Africa "MENA" region: injecting drug users (IDUs) is an under-investigated population.

Authors:  S Ramia; N M Melhem; K Kreidieh
Journal:  Infection       Date:  2012-01-12       Impact factor: 3.553

5.  Hepatitis B Infection among high risk population: a seroepidemiological survey in Southwest of Iran.

Authors:  Abdolmajid Khosravani; Bahador Sarkari; Halimeh Negahban; Asghar Sharifi; Mehdi Akbartabar Toori; Owrang Eilami
Journal:  BMC Infect Dis       Date:  2012-12-27       Impact factor: 3.090

6.  Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide.

Authors:  Ahmed Zidan; Hubert Scheuerlein; Silke Schüle; Utz Settmacher; Falk Rauchfuss
Journal:  Hepat Mon       Date:  2012-10-24       Impact factor: 0.660

7.  Decreasing prevalence of transfusion transmitted infection in Indian scenario.

Authors:  Tulika Chandra; S Nishat Fatima Rizvi; Devisha Agarwal
Journal:  ScientificWorldJournal       Date:  2014-01-27

8.  Prevalence and risk factors of hepatitis C virus infection in amol city, north of iran: a population-based study (2008-2011).

Authors:  Farhad Zamani; Masoudreza Sohrabi; Hossein Poustchi; Hossein Keyvani; Fatemeh Sima Saeedian; Hossein Ajdarkosh; Mahood Khoonsari; Gholamreza Hemmasi; Maziar Moradilakeh; Nima Motamed; Masoumeh Maadi
Journal:  Hepat Mon       Date:  2013-12-07       Impact factor: 0.660

9.  Prevalence and trend of hepatitis C virus infection among blood donors in Iran: A systematic review and meta-analysis.

Authors:  Mazaher Khodabandehloo; Daem Roshani; Kourosh Sayehmiri
Journal:  J Res Med Sci       Date:  2013-08       Impact factor: 1.852

Review 10.  The HBsAg Prevalence Among Blood Donors From Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Meta-Analysis.

Authors:  Mehran Babanejad; Neda Izadi; Farid Najafi; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2016-03-26       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.